De Quervain’s Tenosynovitis Virally Exacerbated by SARS-CoV-2 and Influenza Infections: A Case Report
We present the case of a fully vaccinated 39-year-old male with no pertinent past medical history who initially presented with De Quervain’s tenosynovitis which was successfully treated with a corticosteroid injection. His symptoms recurred during a COVID-19 infection, which was treated with a repea...
Saved in:
Main Authors: | Maria Gergoudis, Logan Laubach, Glenn E. Lee, Jeffrey R. Donowitz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Case Reports in Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/crdi/5117572 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprehensive Insights into De Quervain’s Tenosynovitis: From Etiology to Rehabilitation
by: Piotr Charzewski, et al.
Published: (2025-02-01) -
Morbidity of SARS-CoV-2 in the evolution to endemicity and in comparison with influenza
by: Istvan Bartha, et al.
Published: (2024-11-01) -
Prevalence of De Quervain’s Tenosynovitis among Teenage Mobile Users: A Cross-Sectional Study
by: Mohammad Rehan Asad, et al.
Published: (2024-12-01) -
Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far
by: Radi Taha Alsafi
Published: (2022-01-01) -
Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA
by: Vipan Kumar Sohpal
Published: (2020-09-01)